Sale by Thomas Catinazzo (Chief Financial Officer)
17,717 shares · @ $12.86 · $227,841
Relay Therapeutics, Inc. Common Stock · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) · Now $14.26
+18% in 7d after detection
Post-detection moves
1h
—
1d
-0.8%
3d
+6.7%
7d
+18%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS